Optimizing Use of SGLT2 Inhibitors and Other Evidence-Based Therapies to Improve Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists
Roles
Author
Document Type
Article
Publication Date
1-1-2022
Recommended Citation
Neumiller, J. J., Shubrook, J. H., Manley, T., Alicic, R. Z., & Tuttle, K. R. (2022). Optimizing Use of SGLT2 Inhibitors and Other Evidence-Based Therapies to Improve Outcomes in Patients with Type 2 Diabetes and Chronic Kidney Disease: An Opportunity for Pharmacists. American Journal of Health-System Pharmacy, 79 (1), e65-e70. https://doi.org/10.1093/ajhp/zxab271
